Argo Biopharma

Developer of oligonucleotide therapeutics for various diseases

placeShanghai, Shanghai, China calendar_todayFounded 2021 language argobiopharma.com

Social engagement

Social engagement: 1.4K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Loayal Valley Capital, Tao Capital, TIF, GSR United Capital.

Investor typeCountShare
Venture capital229%
Private equity457%
Other / undisclosed114%

Hiring activity

Hires periodically

6 roles tracked across 3 of the last 12 months

30 Dec 2025 · DRE scientist · Shanghai Zhangjiang Science City

12 Dec 2025 · DRE scientists

4 Dec 2025 · IP Head

28 Nov 2025 · chemist

22 Oct 2025 · Scientist specializing in Skeletal Muscle Metabolism

Based on job postings tracked across public sources.

Coming soon